You are here

  • Home
  • Archive
  • Volume 76, Issue Suppl 2
  • SAT0161 Preliminary real world data on switching patterns between etanercept, its recently marketed biosimilar counterpart and its competitor adalimumab, using swedish prescription registry

Article metrics

Article menu

Download PDFPDF

Poster Presentations
Rheumatoid arthritis - anti-TNF therapy
SAT0161 Preliminary real world data on switching patterns between etanercept, its recently marketed biosimilar counterpart and its competitor adalimumab, using swedish prescription registry
Free

 

Online download statistics by month:

Online download statistics by month: June 2017 to August 2024

AbstractFullPdf
Jun 201786010
Jul 20175803
Aug 201748012
Sep 20174401
Oct 20172405
Nov 20172600
Dec 20177200
Jan 201810807
Feb 20185402
Mar 20183600
Apr 20184802
May 20182600
Jun 20182601
Jul 20183800
Aug 20183200
Sep 20181800
Oct 201822015
Nov 20183608
Dec 201834010
Jan 20192603
Feb 20191704
Mar 20191209
Apr 2019806
May 2019402
Jun 2019403
Jul 20191602
Aug 20191003
Sep 20191004
Oct 20191504
Nov 2019504
Dec 20191303
Jan 2020201
Feb 20201406
Mar 2020301
Apr 20201708
May 2020402
Jun 20201800
Jul 2020902
Aug 2020204
Sep 20201601
Oct 2020401
Nov 2020603
Dec 20201805
Jan 2021201
Feb 2021602
Mar 2021601
Apr 2021801
May 2021203
Jun 2021001
Jul 2021104
Aug 2021203
Sep 2021102
Oct 202110015
Nov 20216012
Dec 2021202
Feb 2022600
Mar 2022202
Apr 20221000
May 2022806
Jun 2022703
Jul 20221600
Aug 20221103
Sep 2022208
Oct 20221102
Nov 202211014
Dec 2022801
Jan 2023401
Feb 2023200
Mar 2023800
Apr 2023403
May 2023204
Jul 2023204
Aug 2023002
Sep 2023001
Dec 20231202
Jan 2024801
Feb 2024602
Mar 20248023
Apr 20241309
May 20241807
Jun 2024600
Jul 2024404
Aug 2024203
Total13260309